- JP-listed companies
- TOWA PHARMACEUTICAL CO.,LTD.
- Balance sheet
TOWA PHARMACEUTICAL CO.,LTD.【JP:4553】Balance sheet
Market cap
¥186.5B
P/E ratio
10.1x
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 3,009 | 20,526 | 9,444 | 14,247 | 26,762 | 18,713 | 22,915 | 32,830 | 24,257 | 29,650 | 45,471 |
| Marketable securities, current | - | 3,198 | 5,000 | 6,000 | 10,999 | 4,999 | - | - | - | - | - | - |
| Accounts receivable, net | - | 22,669 | 19,818 | 19,627 | 24,185 | 27,905 | 35,191 | 38,122 | 42,896 | 46,795 | 62,916 | 61,449 |
| Inventories | - | 16,677 | 21,039 | 22,510 | 17,609 | 17,591 | 24,130 | 30,083 | 32,098 | 44,457 | 48,986 | 44,770 |
| Total current assets | - | 66,642 | 95,132 | 86,552 | 95,377 | 108,206 | 120,375 | 137,290 | 166,864 | 182,990 | 217,718 | 247,306 |
| Property, plant and equipment, net | - | 50,577 | 58,770 | 74,904 | 76,989 | 73,663 | 79,330 | 85,898 | 100,857 | 127,004 | 153,642 | 168,423 |
| Marketable securities, non-current | - | 1,900 | 564 | 531 | 427 | 451 | 455 | 519 | 464 | 676 | 641 | 871 |
| Total non-current assets | - | 54,544 | 61,719 | 78,695 | 81,947 | 80,597 | 107,763 | 108,378 | 163,071 | 188,357 | 212,934 | 223,517 |
| Total assets | - | 121,187 | 156,851 | 165,247 | 177,325 | 188,803 | 228,138 | 245,668 | 329,935 | 371,347 | 430,653 | 470,823 |
| Accounts payable | - | 12,577 | 6,954 | 5,309 | 5,385 | 6,466 | 9,585 | 10,000 | 14,834 | 17,272 | 15,652 | 17,918 |
| Short-term debt | - | 1,490 | 1,740 | 1,740 | 850 | 850 | 21,368 | 1,111 | 49,335 | 3,677 | 3,112 | 4,699 |
| Long-term debt, current | - | 2,505 | 2,033 | 2,681 | 4,249 | 6,396 | 6,767 | 7,181 | 8,022 | 7,527 | 10,120 | 18,023 |
| Total current liabilities | - | 31,054 | 31,262 | 34,601 | 35,904 | 37,177 | 69,468 | 51,516 | 115,073 | 78,529 | 80,118 | 87,939 |
| Long-term debt, non-current | - | 18,468 | 38,435 | 39,253 | 44,803 | 43,407 | 36,640 | 69,945 | 79,194 | 150,314 | 189,124 | 195,077 |
| Total non-current liabilities | - | 20,085 | 54,984 | 55,701 | 61,501 | 59,854 | 54,020 | 77,552 | 82,692 | 155,923 | 194,641 | 211,259 |
| Total liabilities | - | 51,139 | 86,246 | 90,302 | 97,405 | 97,032 | 123,489 | 129,069 | 197,766 | 234,453 | 274,759 | 299,198 |
| Common stock and paid-in capital | - | 12,587 | 12,587 | 12,587 | 12,587 | 12,587 | 12,587 | 12,551 | 12,554 | 12,554 | 12,555 | 12,558 |
| Retained earnings | - | 57,893 | 63,821 | 67,879 | 72,816 | 84,734 | 97,171 | 108,629 | 122,131 | 121,232 | 134,452 | 150,502 |
| Stockholders' equity | 60,147 | 70,048 | 70,605 | 74,945 | 79,920 | 91,771 | 104,649 | 116,599 | 132,169 | 136,894 | 155,893 | 171,625 |